药品名称 | MELLARIL-S | 申请号 | 017923 | 产品号 | 002 | 活性成分 | THIORIDAZINE | 市场状态 | 停止上市 | 剂型或给药途径 | SUSPENSION;ORAL | 规格 | EQ 100MG HCL/5ML | 治疗等效代码 | | 参比药物 | 否 | 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
| 化学类型 | New dosage form | 审评分类 | Standard review drug |
|
|
与本品相关的专利信息(来自橙皮书Orange Book) | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | 无 | 历史专利信息 | 无 |
|
与本品相关的市场独占权保护信息 | 独占权代码 | 失效日期 | 无 | 历史市场独占权保护信息 | 无 |
|
与药品注册相关的信息 | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | 017923 | 049 | AP | Letter | 2001/03/15 | 下载 |
|
药品注册审批历史信息 | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | 017923 | 049 | AP | 2001/03/15 | Labeling Revision | 017923 | 048 | AP | 2000/06/19 | Labeling Revision | 017923 | 035 | AP | 1989/05/02 | Control Supplement | 017923 | 032 | AP | 1987/08/20 | Control Supplement | 017923 | 031 | AP | 1987/05/26 | Control Supplement | 017923 | 029 | AP | 1987/04/23 | Control Supplement | 017923 | 028 | AP | 1987/03/13 | Formulation Revision | 017923 | 027 | AP | 1986/10/06 | Labeling Revision | 017923 | 026 | AP | 1986/10/06 | Labeling Revision | 017923 | 025 | AP | 1986/11/10 | Control Supplement | 017923 | 023 | AP | 1988/11/15 | Control Supplement | 017923 | 022 | AP | 1986/06/10 | Control Supplement | 017923 | 016 | AP | 1982/09/20 | Manufacturing Change or Addition | 017923 | 015 | AP | 1982/09/13 | Manufacturing Change or Addition | 017923 | 014 | AP | 1982/04/30 | Manufacturing Change or Addition | 017923 | 012 | AP | 1981/01/13 | Package Change | 017923 | 011 | AP | 1981/03/18 | Formulation Revision | 017923 | 010 | AP | 1981/01/09 | Package Change | 017923 | 008 | AP | 1980/04/10 | Formulation Revision | 017923 | 007 | AP | 1980/04/15 | Manufacturing Change or Addition | 017923 | 006 | AP | 1979/10/15 | Other Amendment | 017923 | 005 | AP | 1979/10/15 | Package Change | 017923 | 004 | AP | 1979/06/14 | Package Change | 017923 | 003 | AP | 1979/09/11 | Package Change | 017923 | 002 | AP | 1980/04/15 | Manufacturing Change or Addition | 017923 | 000 | AP | 1978/10/18 | Approval |
|